Submit News | Submit Press Releases | Create Profile | News Pricing | Become an Affiliate | RSS | Alerts | WooEB    
Financial News

Small Cap Stocks Beating The Morning’s Down Trend: NEXM, TGEN - sourced PicksThatMove.com

NexMed, Inc., Targeted Genetics Corporation

Calgary, AB 11/24/2009 05:03 PM GMT (TransWorldNews)

 

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

 

Small Cap Stocks Beating The Morning’s Down Trend: NEXM, TGEN

 

The hot stock information of the day includes: NEXM, TGEN

 

Stocks slide this morning on news the US economy is growing slower than estimated. The humble 2.8% rate of growth was blamed primarily on imports and a decline in investments in non-residential structures, which tumbled 15.1%.

 

NexMed, Inc. (NASDAQ:NEXM) jumped 63.32% up to $0.323 on news NexMed, Inc will acquire  privately owned research organization Bio-Quant  Inc .  Bio-Quant Inc conducts in vitro and in vivo contract drug discovery and pre-clinical development services in San Diego, California, specializing in oncology, inflammation, immunology, and metabolic diseases. The acquisition provides for NexMed's issuance of 4,000,000 unregistered shares of its common stock to the Bio-Quant shareholders and a promissory note in the amount of approximately $12.1 million due on December 31, 2010.  Upon closing of the transaction Bio-Quant will become a wholly-owned subsidiary of NexMed. Headquartered in East Windsor, New Jersey, NexMed, Inc. develops bio-enhancement drug delivery technology known as NexACT, which enables an active drug to be better absorbed through the skin.  

 

Targeted Genetics Corporation (NASDAQ:TGEN) rose 16.67% up to $0.280 on no news. Based in Seattle, Washington, Targeted Genetics Corporation is a clinical-stage biotech company which researches and develops gene therapy products and technologies for treating various diseases.  The company currently has clinical trials for vaccine and treatment candidates for HIV, heart failure, inflammatory arthritis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis and amyotrophic lateral sclerosis.

 

To be kept up to date on all of our hot stock information join us at Picks That Move.

 

About PicksThatMove.com:

 

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter  

 

info@picksthatmove.com
picksthatmove.com

Empty Image

Empty Image

   |    View Profile

Visit Blogs                           |    Bookmark and Share

Empty Image

NEWS ALERTS

Receive alerts for NEXM to your inbox. Sign up for TransWorldNews Alerts

Empty Image

TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.

Empty Image

Empty Image